Global Patent Index - EP 1309344 A1

EP 1309344 A1 20030514 - ORAL SOLID DOSE VACCINE

Title (en)

ORAL SOLID DOSE VACCINE

Title (de)

EINE FESTE DOSISFORM ENTHALTENDER IMPSTOFF ZUR ORALEN ANWENDUNG

Title (fr)

VACCIN ORAL SOUS FORME DE DOSE SOLIDE

Publication

EP 1309344 A1 20030514 (EN)

Application

EP 01965535 A 20010814

Priority

  • GB 0020089 A 20000815
  • IB 0101711 W 20010814

Abstract (en)

[origin: WO0213858A1] The present invention relates to novel vaccine formulations suitable for oral administration. The vaccine formulations are in a solid form comprising antigen and suitable excipient, which after insertion into the mouth, rapidly dissolve in saliva, thereby releasing the vaccine into the mouth. Specifically, the solid form may consist of a cake of vaccine which is formed from a liquid solution or suspension by sublimation, preferably sublimation by lyophilisation. Preferred vaccines are those containing antigens which are derived from pathogens that normally infect or invade the host through a mucosal membrane, or those vaccines that further comprises an antacid. Particularly preferred vaccines are combination vaccines that comprise more than one antigen, and more preferably when the antigens are from more than one pathogen.

IPC 1-7

A61K 39/39; A61K 39/00; A61K 9/20; A61K 39/02; A61K 39/12

IPC 8 full level

A61K 9/00 (2006.01); A61K 39/00 (2006.01); A61K 39/02 (2006.01); A61K 39/12 (2006.01); A61K 39/145 (2006.01); A61K 39/39 (2006.01); A61K 47/02 (2006.01); A61K 47/04 (2006.01); A61K 47/10 (2006.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01); A61P 31/00 (2006.01); A61K 9/20 (2006.01)

CPC (source: EP KR US)

A61K 9/0053 (2013.01 - EP US); A61K 39/39 (2013.01 - KR); A61P 31/00 (2018.01 - EP); A61K 9/2095 (2013.01 - EP US); A61K 2039/541 (2013.01 - EP US); Y02A 50/30 (2018.01 - EP US)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0213858 A1 20020221; AU 2001286168 B2 20040923; AU 8616801 A 20020225; BR 0113301 A 20030715; CA 2424160 A1 20020221; CN 1842345 A 20061004; EP 1309344 A1 20030514; GB 0020089 D0 20001004; HU P0301697 A2 20030828; HU P0301697 A3 20041129; IL 154404 A0 20030917; JP 2004506020 A 20040226; KR 20030031978 A 20030423; MX PA03001392 A 20041213; NO 20030713 D0 20030214; NO 20030713 L 20030411; NZ 524164 A 20041029; PL 362481 A1 20041102; US 2004013695 A1 20040122; ZA 200301210 B 20040312

DOCDB simple family (application)

IB 0101711 W 20010814; AU 2001286168 A 20010814; AU 8616801 A 20010814; BR 0113301 A 20010814; CA 2424160 A 20010814; CN 01817392 A 20010814; EP 01965535 A 20010814; GB 0020089 A 20000815; HU P0301697 A 20010814; IL 15440401 A 20010814; JP 2002518997 A 20010814; KR 20037002236 A 20030215; MX PA03001392 A 20010814; NO 20030713 A 20030214; NZ 52416401 A 20010814; PL 36248101 A 20010814; US 34479803 A 20030804; ZA 200301210 A 20030213